Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05331664 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dropless Pars Plana Vitrectomy Study

Study acronym: DVS
StatusCompleted
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 7 more changesShow less
    • Study completion date changed from estimate of Jan 30, 2027 to Aug 30, 2026
    • Interventions: Atropine 1% (Drug), Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin (Drug), Pars plana vitrectomy… to Atropine 1% (Drug), Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin (Drug), Pars plana vitrectomy…
    • Eligibility criteria expanded, about 24 words
    • Secondary endpoints: details revised at 2 of 10 entries
    • Site details revised
    • Publications: details revised at 4 of 4 entries
    • Study description expanded, about 2 words
  2. Re-verified, no change to tracked fieldsv7
  3. Primary completion date: Jul 25, 2025 to Jul 25, 2026
    • Study completion date: Jan 30, 2026 to Jan 30, 2027
    v6
  4. Re-verified, no change to tracked fieldsv5
  5. Eligibility criteria shortened, about 5 wordsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Jun 1, 2025 to Jul 25, 2025
    • Study completion date: Dec 30, 2025 to Jan 30, 2026
    • Start date changed from estimate of Jun 1, 2022 to Jul 25, 2022
  2. Start date: May 1, 2022 to Jun 1, 2022
    • Primary completion date: May 1, 2025 to Jun 1, 2025
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regimen of postoperative eye drops following primary pars plana vitrectomy for retinal detachment.
Trial Details
NCT Number NCT05331664
Lead Sponsor Massachusetts Eye and Ear Infirmary
Conditions
(from sponsor)		 Rhegmatogenous Retinal Detachment
Related terms Inflammation
Enrollment 168 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov